We are live on ! Find out more
MSOS icon

AdvisorShares Pure US Cannabis ETF

151 hedge funds and large institutions have $72.4M invested in AdvisorShares Pure US Cannabis ETF in 2025 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 36 increasing their positions, 41 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

360% more call options, than puts

Call options by funds: $15.3M | Put options by funds: $3.32M

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

2.89% less ownership

Funds ownership: 25.6%22.71% (-2.9%)

4% less funds holding

Funds holding: 157151 (-6)

12% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 41

18% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 22

20% less capital invested

Capital invested by funds: $90.7M → $72.4M (-$18.3M)

Holders
151
Holders Change
-6
Holders Change %
-3.82%
% of All Funds
1.99%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
18
Increased
36
Reduced
41
Closed
22
Calls
$15.3M
Puts
$3.32M
Net Calls
+$11.9M
Net Calls Change
+$10.5M
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$444K +$13K +5,279 +3%
CL
27
CSS LLC
Illinois
$429K +$36.9K +15,000 +9%
Citadel Advisors
28
Citadel Advisors
Florida
$401K -$670K -272,378 -62%
BFM
29
Boothbay Fund Management
New York
$388K -$755K -306,696 -66%
SCP
30
Sender Company & Partners
New York
$386K +$394K +160,265 New
FCH
31
Freestone Capital Holdings
Washington
$363K +$371K +150,681 New
Parallax Volatility Advisers
32
Parallax Volatility Advisers
California
$362K +$2.28K +927 +0.6%
CC
33
Centiva Capital
New York
$362K +$226K +92,000 +159%
CCA
34
Cruiser Capital Advisors
Connecticut
$356K -$375K -152,400 -51%
Corient Private Wealth
35
Corient Private Wealth
Florida
$344K +$240K +97,426 +215%
PAG
36
Private Advisor Group
New Jersey
$319K -$59.7K -24,259 -15%
PCP
37
Proficio Capital Partners
Massachusetts
$312K -$1.16M -472,450 -78%
ECM
38
Evergreen Capital Management
Washington
$297K +$7.38K +3,000 +2%
GWM
39
Geneos Wealth Management
Colorado
$273K -$311K -126,414 -53%
TC
40
Tejara Capital
United Kingdom
$234K +$239K +97,000 New
VVP
41
Venture Visionary Partners
Ohio
$212K +$60.9K +24,755 +39%
ADBIC
42
A.D. Beadell Investment Counsel
Wisconsin
$197K +$201K +81,800 New
EL
43
EWA LLC
Pennsylvania
$195K
KA
44
Kerrisdale Advisers
Florida
$187K
FIA
45
FNY Investment Advisers
New York
$184K +$44.9K +18,235 +31%
MFIM
46
Mesirow Financial Investment Management
Illinois
$184K
NW
47
NewEdge Wealth
Pennsylvania
$182K -$14.9K -6,048 -10%
Janney Montgomery Scott
48
Janney Montgomery Scott
Pennsylvania
$181K -$158K -64,300 -46%
IWM
49
IHT Wealth Management
Illinois
$167K +$2.18K +887 +1%
ZIG
50
Zuckerman Investment Group
Illinois
$162K -$209K -85,000 -56%

MSOS Hedge Fund Activity: Q2 2025 in Review

151 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in AdvisorShares Pure US Cannabis ETF (MSOS) for Q2 2025, worth a combined $72.4M — down 20% from $90.7M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of MSOS and 18 opened new positions — a net loss of 4 holders — while 41 trimmed existing stakes and 36 added.

The largest buyer was Group One Trading, adding an estimated $1.88M. The largest seller was Eminence Capital, exiting entirely with an estimated $3.87M sold.

  • 151 institutional investors held AdvisorShares Pure US Cannabis ETF (MSOS) as of Q2 2025, down from 157 in Q1 2025.
  • Funds reported $72.4M of AdvisorShares Pure US Cannabis ETF stock for Q2 2025, down 20% quarter-over-quarter.
  • 18 funds opened new AdvisorShares Pure US Cannabis ETF positions in Q2 2025 and 22 closed out, a net change of -4 holders.
  • The largest AdvisorShares Pure US Cannabis ETF buyer in Q2 2025 was Group One Trading, an estimated $1.88M added.
  • The largest AdvisorShares Pure US Cannabis ETF seller in Q2 2025 was Eminence Capital, an estimated $3.87M sold.

Based on aggregated 13F filings for Q2 2025.